Changeflow GovPing Healthcare & Life Sciences Random Controlled Trial of Home-Based Digital T...
Routine Notice Added Final

Random Controlled Trial of Home-Based Digital Therapy for ADHD in Children

Favicon for changeflow.com ClinicalTrials.gov Studies
Published
Detected
Email

Summary

NIH registered a new randomized controlled trial (NCT07552909) on ClinicalTrials.gov to evaluate the efficacy of home-based digital neurofeedback games as an intervention for school-aged children diagnosed with mild to moderate ADHD. The study will explore the effects of brain-controlled games on core ADHD symptoms. This registry entry establishes the formal study record and intervention protocol. No compliance obligations or enforcement actions are associated with this registration.

“Explore the interventional effects of neurofeedback games on school-aged children with mild to moderate ADHD, with the aim of providing evidence-based new methods for intervening in the core symptoms of ADHD in children.”

NLM , verbatim from source
Published by NLM on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

ClinicalTrials.gov is the NIH-run registry of every clinical trial conducted in the United States, plus most international trials sponsored by US-based companies or institutions. By federal law, sponsors must register Phase 2 through Phase 4 studies before enrolling patients and post results within a year of completion. This feed tracks every new trial registration and study update, around 700 a month: drug interventions, device studies, behavioral protocols, observational research. Watch this if you scout drug candidates moving into mid or late-stage development, monitor competitor pipelines, or follow rare disease research where new trials signal patient hope. GovPing parses sponsor, phase, intervention, and target indication on each entry.

What changed

The ClinicalTrials.gov registry entry for NCT07552909 establishes a new randomized controlled trial to investigate the use of home-based digital neurofeedback games as a therapeutic intervention for children with ADHD. The study targets school-aged children with mild to moderate attention deficit hyperactivity disorder. No regulatory compliance obligations are created by this registry entry; it is an informational record of planned research.

For clinical investigators and healthcare providers, this registry entry signals active interest in digital therapeutic approaches for pediatric ADHD. Researchers conducting related studies in neurofeedback or digital health interventions for pediatric populations may find this trial relevant for study design considerations or potential collaboration.

Archived snapshot

Apr 28, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← ClinicalTrials.gov Studies

A Random Controlled Trial of Home-based Digital Therapy for Treating ADHD in Children

N/A NCT07552909 Kind: NA Apr 27, 2026

Abstract

Explore the interventional effects of neurofeedback games on school-aged children with mild to moderate ADHD, with the aim of providing evidence-based new methods for intervening in the core symptoms of ADHD in children.

Conditions: Attention Deficit Hyperactivity Disorder (ADHD)

Interventions: Home-based digital therapy with brain-controlled games

View original document →

Get daily alerts for ClinicalTrials.gov Studies

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from NLM.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
NLM
Published
April 27th, 2026
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Clinical investigators Healthcare providers
Industry sector
6211 Healthcare Providers
Activity scope
Clinical trial registration Neurofeedback research Pediatric ADHD therapy
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Clinical Operations
Topics
Public Health Pharmaceuticals

Get alerts for this source

We'll email you when ClinicalTrials.gov Studies publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!